Device / Technology News

RSS

Elastography and serum markers show promise in patients with liver disease

Patients who are evaluated for liver diseases such as hepatitis C (HCV) are typically recommended for liver biopsy to determine the extent of disease progression.

3 Jun 2011

Bruker to showcase record performance achievements of maXis 4G system at ASMS 2011

Bruker, the pioneer of ultrahigh-resolution quadrupole time-of-flight mass spectrometry, today announced a major extension of the successful maXis UHR Qq-TOF technology range, which Bruker will showcase at the ASMS 2011 conference in Denver, Colorado, starting this Sunday, June 5.

3 Jun 2011

IDEV completes enrollment in SUPERA stent trial for treatment of peripheral artery disease

IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.

3 Jun 2011

Rheonix to receive U.S. patent for powerful microfluidic platform

Rheonix, Inc., developer of the Rheonix CARD system that provides a powerful microfluidic platform for the evolving molecular diagnostics industry, announced that on June 14, 2011 the U.S. Patent and Trademark Office will issue Patent Number 7,959,875, "Microfluidic Chips and Assay Systems," and on April 13, 2011 it allowed Patent Application Number 11/594,444, "Microfluidic Systems," to the Company.

3 Jun 2011

VisiInc and MMRGlobal announce agreement to launch MyMedicalRecords in Australia

MMRGlobal, Inc. and VisiInc PLC (VZJ) have entered into an agreement to launch MMRGlobal’s patented consumer and professional health IT products and services, including MMRPro for healthcare professionals (www.mmrprovideos.com) and the MyMedicalRecords Personal Health Record (PHR) (www.mmrvideos.com), on the Visi™ platform utilizing the Vistime product. Initially, the two companies will collaborate on offering products and services jointly to the health technology market in Australia, which is currently projected to be as much as $2.4 billion this year.

2 Jun 2011

RACGP committed to supporting telehealth in general practice

The Royal Australian College of General Practitioners (RACGP) recognises that telehealth provides considerable opportunities to improve health outcomes for patients in outer metropolitan, regional, rural and remote communities and is committed to supporting the profession during the telehealth rollout.

2 Jun 2011

Biowave II UV-Vis spectrophotometers for low volume DNA measurements: Special offer

A great solution for measuring DNA in low volume samples, Biowave II / II+ UV-Vis spectrophotometers from Biochrom now come with 500 70µl disposable cuvettes and a 100 µl pipette free of charge. To take advantage of this offer, please contact your local distributor or send an email to [email protected]

From Biochrom Ltd. 2 Jun 2011

Mild brain injury tracked using special MRI technique

According to a new study there may be an explanation of why some military personnel exposed to blasts have symptoms of brain injury even though their CT and MRI scans look normal.

2 Jun 2011

Medicomp releases Quippe, browser-based clinical documentation software development kit

Medicomp Systems announces the release of Quippe, its latest innovation to support usability of clinical systems at the point of care. It is a browser-based clinical documentation software development kit available for licensing by electronic medical record system developers.

2 Jun 2011

Bio-Tissue ships over 7,500 ProKera medical device since product's inception

Bio-Tissue, the industry leader in Ophthalmic tissue products, announced today that it has shipped over 7,500 ProKera units since the product's inception. ProKera is the only medical device that can provide wound healing to over 350,000 annual cases of patients afflicted with damaged ocular surfaces.

2 Jun 2011

Clovis Oncology, Roche partner to develop in vitro PCR-based diagnostic test for NSCLC

Clovis Oncology, Inc. and Roche, announced today that they have entered into an agreement to develop an in vitro PCR based companion diagnostic test.

2 Jun 2011

OncoSec Medical to present results of ElectroImmunotherapy clinical trial in melanoma at ASCO 2011

OncoSec Medical Incorporated, which is developing its advanced-stage ElectroOncology therapies to treat solid tumor cancers, announced today that one of its clinical trial advisers will present results from an ElectroImmunotherapy clinical trial for melanoma at the 2011 American Society of Clinical Oncology Annual Meeting to be held June 4-8 at McCormick Place, Chicago, IL.

2 Jun 2011

Diffusion tensor imaging detects brain abnormalities in U.S. military personnel with mild traumatic brain injury

An advanced imaging technique has revealed that some U.S. military personnel with mild blast-related traumatic brain injuries have abnormalities in the brain that have not been seen with other types of imaging.

2 Jun 2011

WHO/IARC say mobile phone use may increase risk of certain brain cancers

Mobile phone use "may increase the risk of certain types of brain cancer in humans," therefore "consumers should consider ways of reducing their exposure," a WHO/International Agency for Research on Cancer (IARC) working group concluded on Tuesday, Reuters reports.

2 Jun 2011

Cell phone use poses no cancer risk, says JunkScience publisher

Today's media hoopla about the World Health Organization classifying cell phone use as "possibly carcinogenic" is much ado about nothing. The studies the WHO relies on are weak association studies that have zero reliability.

2 Jun 2011

Study affirms effectiveness of palliative care discussions before LVAD heart surgery

For patients with severe heart failure, an implanted mechanical pump known as a Left Ventricular Assist Device (LVAD) can be a life-sustaining treatment. Even though the technology involves risks, few patients and their families tend to talk explicitly about the "what ifs" before surgery takes place.

2 Jun 2011

Positive results from Nuvilex European Phase II trial against pancreatic cancer

Nuvilex, Inc. announces the favorable results of a completed Phase II clinical trial carried out in Europe against pancreatic cancer. The treatment technology used in this trial was recently acquired by Nuvilex.

2 Jun 2011

Google launches Dengue Trends tool to track outbreaks

"Google has launched Dengue Trends, a tool that aims to detect dengue fever outbreaks around the world using the same methodology behind Google Flu Trends," PC Magazine reports.

2 Jun 2011

Free online WHO Fracture Risk Assessment Tool now available as version 3.3

The WHO Fracture Risk Assessment Tool (FRAX-) is an important new calculation tool, available free online at http://www.shef.ac.uk/FRAX, that is being used by a steadily increasing number of physicians around the world to calculate a patient's 10-year probability of fracture based on scientifically validated risk factors.

2 Jun 2011

Baseline concussion tests could increase risks to athletes

Baseline concussion tests given to hundreds of thousands of athletes might, paradoxically, increase risks in some cases, according to a Loyola University Health System researcher.

2 Jun 2011

Device / Technology News

Elastography and serum markers show promise in patients with liver disease

Bruker to showcase record performance achievements of maXis 4G system at ASMS 2011

IDEV completes enrollment in SUPERA stent trial for treatment of peripheral artery disease

Rheonix to receive U.S. patent for powerful microfluidic platform

VisiInc and MMRGlobal announce agreement to launch MyMedicalRecords in Australia

RACGP committed to supporting telehealth in general practice

Biowave II UV-Vis spectrophotometers for low volume DNA measurements: Special offer

Mild brain injury tracked using special MRI technique

Medicomp releases Quippe, browser-based clinical documentation software development kit

Bio-Tissue ships over 7,500 ProKera medical device since product's inception

Clovis Oncology, Roche partner to develop in vitro PCR-based diagnostic test for NSCLC

OncoSec Medical to present results of ElectroImmunotherapy clinical trial in melanoma at ASCO 2011

Diffusion tensor imaging detects brain abnormalities in U.S. military personnel with mild traumatic brain injury

WHO/IARC say mobile phone use may increase risk of certain brain cancers

Cell phone use poses no cancer risk, says JunkScience publisher

Study affirms effectiveness of palliative care discussions before LVAD heart surgery

Positive results from Nuvilex European Phase II trial against pancreatic cancer

Google launches Dengue Trends tool to track outbreaks

Free online WHO Fracture Risk Assessment Tool now available as version 3.3

Baseline concussion tests could increase risks to athletes

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News